2020 Q2 Form 10-Q Financial Statement

#000156459021044300 Filed on August 13, 2021

View on sec.gov

Income Statement

Concept 2020 Q2
Revenue $9.661M
YoY Change 10.41%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $380.0K
YoY Change 31.03%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $904.0K
YoY Change -14.8%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $3.413M
YoY Change 37.23%
Income Tax $594.0K
% Of Pretax Income 17.4%
Net Earnings $2.819M
YoY Change 32.6%
Net Earnings / Revenue 29.18%
Basic Earnings Per Share $0.83
Diluted Earnings Per Share $0.83
COMMON SHARES
Basic Shares Outstanding 3.410M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $38.36M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $19.05M
YoY Change -0.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.023B
YoY Change 22.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $4.200M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.200M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $9.300M
YoY Change -5.1%
Total Long-Term Liabilities $9.300M
YoY Change -5.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.200M
Total Long-Term Liabilities $9.300M
Total Liabilities $921.3M
YoY Change 24.38%
SHAREHOLDERS EQUITY
Retained Earnings $78.39M
YoY Change 9.48%
Common Stock $8.473M
YoY Change -0.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $101.6M
YoY Change
Total Liabilities & Shareholders Equity $1.023B
YoY Change 22.72%

Cashflow Statement

Concept 2020 Q2
OPERATING ACTIVITIES
Net Income $2.819M
YoY Change 32.6%
Depreciation, Depletion And Amortization $380.0K
YoY Change 31.03%
Cash From Operating Activities $1.890M
YoY Change -15.63%
INVESTING ACTIVITIES
Capital Expenditures -$130.0K
YoY Change -27.78%
Acquisitions
YoY Change
Other Investing Activities -$103.6M
YoY Change 507.03%
Cash From Investing Activities -$103.7M
YoY Change 501.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 117.1M
YoY Change 453.97%
NET CHANGE
Cash From Operating Activities 1.890M
Cash From Investing Activities -103.7M
Cash From Financing Activities 117.1M
Net Change In Cash 15.32M
YoY Change 149.51%
FREE CASH FLOW
Cash From Operating Activities $1.890M
Capital Expenditures -$130.0K
Free Cash Flow $2.020M
YoY Change -16.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9661000
CY2021Q2 efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
399000
efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
740000
CY2021Q2 efsi Gain On Sale Of Loans Held For Sale
GainOnSaleOfLoansHeldForSale
359000
efsi Gain On Sale Of Loans Held For Sale
GainOnSaleOfLoansHeldForSale
359000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
223000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
143000
us-gaap Noninterest Income Other
NoninterestIncomeOther
610000
us-gaap Noninterest Income Other
NoninterestIncomeOther
35000
CY2020Q2 us-gaap Noninterest Income
NoninterestIncome
2422000
us-gaap Noninterest Income
NoninterestIncome
5077000
us-gaap Noninterest Income
NoninterestIncome
4112000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
10026000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
8461000
us-gaap Occupancy Net
OccupancyNet
869000
us-gaap Occupancy Net
OccupancyNet
798000
us-gaap Equipment Expense
EquipmentExpense
462000
us-gaap Equipment Expense
EquipmentExpense
484000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
306000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
357000
us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
98000
us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
66000
efsi Atm Network Fees
AtmNetworkFees
562000
efsi Atm Network Fees
AtmNetworkFees
485000
efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
5000
efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
-1000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-102000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
132000
CY2021Q2 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
133000
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
240000
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
41000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
470000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
281000
efsi Bank Franchise Tax
BankFranchiseTax
384000
efsi Bank Franchise Tax
BankFranchiseTax
350000
us-gaap Professional Fees
ProfessionalFees
829000
us-gaap Professional Fees
ProfessionalFees
671000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
607000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
19157000
CY2021Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
530000
CY2020Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
715000
CY2020Q4 us-gaap Liabilities
Liabilities
1025078000
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
996000
CY2021Q2 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
107000
CY2020Q2 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
152000
CY2020Q2 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
6000
us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
27000
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
11980000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3405035
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3405035
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
20928
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
8460000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10811000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
82524000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3279000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
105074000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1130152000
CY2020Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8773000
us-gaap Dividend Income Operating
DividendIncomeOperating
24000
CY2021Q2 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
15000
us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
1000
CY2021Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10413000
CY2021Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
118000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
1981000
CY2021Q2 us-gaap Interest Expense
InterestExpense
434000
us-gaap Interest Expense
InterestExpense
921000
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9979000
CY2021Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
284000
CY2020Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
752000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
883000
CY2021Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
9695000
CY2021Q2 efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
241000
CY2020Q2 efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
170000
CY2021Q2 efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
1354000
CY2020Q2 efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
1147000
efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
2663000
CY2021Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-52000
CY2020Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
529000
CY2020Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4373000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
18768000
CY2020Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
879000
CY2020Q2 efsi Interest Expense Borrowings1
InterestExpenseBorrowings1
25000
CY2020Q2 us-gaap Interest Expense
InterestExpense
904000
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8757000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
19508000
CY2020Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
8005000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
18625000
CY2020Q2 efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
403000
CY2020Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
143000
CY2021Q2 us-gaap Noninterest Income Other
NoninterestIncomeOther
231000
CY2020Q2 us-gaap Noninterest Income Other
NoninterestIncomeOther
30000
CY2021Q2 us-gaap Noninterest Income
NoninterestIncome
2650000
CY2021Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
434000
CY2020Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
152000
CY2020Q2 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
34000
CY2020Q2 efsi Atm Network Fees
AtmNetworkFees
243000
CY2020Q2 efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
-3000
CY2020Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
161000
CY2021Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
747000
CY2020Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
483000
CY2021Q2 us-gaap Noninterest Expense
NoninterestExpense
8727000
CY2020Q2 us-gaap Noninterest Expense
NoninterestExpense
7014000
CY2020Q2 us-gaap Occupancy Net
OccupancyNet
403000
CY2021Q2 us-gaap Equipment Expense
EquipmentExpense
238000
CY2020Q2 us-gaap Equipment Expense
EquipmentExpense
252000
CY2021Q2 us-gaap Supplies And Postage Expense
SuppliesAndPostageExpense
60000
CY2021Q2 efsi Atm Network Fees
AtmNetworkFees
312000
CY2021Q2 efsi Other Real Estate Owned Expense
OtherRealEstateOwnedExpense
6000
CY2021Q2 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-92000
CY2020Q2 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
41000
CY2021Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
281000
CY2021Q2 efsi Bank Franchise Tax
BankFranchiseTax
195000
CY2020Q2 efsi Bank Franchise Tax
BankFranchiseTax
176000
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
369000
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
317000
CY2021Q2 efsi Dataprocessingfees
Dataprocessingfees
373000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2819000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2819000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
36000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-361000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-361000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2458000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3413000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
594000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
3003000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
3003000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
9000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-96000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
36000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3039000
CY2021Q2 us-gaap Dividends Common Stock
DividendsCommonStock
926000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
20429000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
921000
efsi Interest Expense Borrowings1
InterestExpenseBorrowings1
25000
us-gaap Interest Expense
InterestExpense
2006000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
16762000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
655000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
16107000
efsi Noninterest Income Fiduciary Activities
NoninterestIncomeFiduciaryActivities
700000
efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
458000
efsi Noninterest Income Service Chargeson Deposit Accounts
NoninterestIncomeServiceChargesonDepositAccounts
454000
efsi Noninterest Income Other Service Chargesand Fees
NoninterestIncomeOtherServiceChargesandFees
2251000
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
24000
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
529000
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5310000
CY2021Q2 us-gaap Occupancy Net
OccupancyNet
413000
CY2021Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
198000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3618000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
615000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
86000
CY2020Q2 efsi Dataprocessingfees
Dataprocessingfees
382000
efsi Dataprocessingfees
Dataprocessingfees
775000
efsi Dataprocessingfees
Dataprocessingfees
863000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1515000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1165000
us-gaap Noninterest Expense
NoninterestExpense
16643000
us-gaap Noninterest Expense
NoninterestExpense
13889000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7059000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6330000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1194000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1070000
us-gaap Net Income Loss
NetIncomeLoss
5865000
us-gaap Net Income Loss
NetIncomeLoss
5260000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.54
us-gaap Net Income Loss
NetIncomeLoss
5865000
us-gaap Net Income Loss
NetIncomeLoss
5260000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-573000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
653000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2157000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2455000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2157000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2455000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3708000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7715000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
96326000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2441000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2816000
CY2020Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
10000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
114000
CY2020Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
3685
CY2020Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
111000
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1500
CY2020Q1 efsi Changes In Shareholder Equity Retirement Of Common Stock
ChangesInShareholderEquityRetirementOfCommonStock
-1116000
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
893000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
99799000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2819000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-361000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
114000
CY2020Q2 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
2761
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
CY2020Q2 us-gaap Dividends Common Stock
DividendsCommonStock
888000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
101569000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
105074000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2862000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2193000
CY2021Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
10258
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
147000
CY2021Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
6260
CY2021Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
181000
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2814
CY2021Q1 efsi Changes In Shareholder Equity Retirement Of Common Stock
ChangesInShareholderEquityRetirementOfCommonStock
-83000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
18488
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
924000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
105064000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
3003000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
36000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
159000
CY2021Q2 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
4702
CY2021Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
158000
CY2021Q2 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
4154
CY2021Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
133000
CY2021Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
760
CY2021Q2 efsi Changes In Shareholder Equity Retirement Of Common Stock
ChangesInShareholderEquityRetirementOfCommonStock
-25000
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
107602000
us-gaap Net Income Loss
NetIncomeLoss
5865000
us-gaap Net Income Loss
NetIncomeLoss
5260000
us-gaap Depreciation
Depreciation
502000
us-gaap Depreciation
Depreciation
516000
efsi Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
218000
efsi Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
216000
us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
5655000
us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
4734000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
359000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
883000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
655000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-102000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
132000
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-2000
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
24000
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
529000
us-gaap Share Based Compensation
ShareBasedCompensation
306000
us-gaap Share Based Compensation
ShareBasedCompensation
228000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-726000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-371000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1956000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2650000
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
164000
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-148000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5506000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3789000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
31404000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
23895000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
15885000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
24893000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
62257000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
25636000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
222000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
2125000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
20928
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
2196000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.98
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
10000000
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
12000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
404000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
266000
us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
155000
us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
183000
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
13000
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-18182000
efsi Proceeds From Origination Of Loans Net Of Principal Collected
ProceedsFromOriginationOfLoansNetOfPrincipalCollected
-58964000
efsi Proceeds From Origination Of Loans Net Of Principal Collected
ProceedsFromOriginationOfLoansNetOfPrincipalCollected
-143762000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65777000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132751000
us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
88880000
us-gaap Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
135659000
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-2580000
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
707000
efsi Issuance Of Common Stock Employee Benefit Plan
IssuanceOfCommonStockEmployeeBenefitPlan
133000
efsi Issuance Of Common Stock Employee Benefit Plan
IssuanceOfCommonStockEmployeeBenefitPlan
86000
efsi Paymentsfor Retirement Of Common Stock
PaymentsforRetirementOfCommonStock
108000
efsi Paymentsfor Retirement Of Common Stock
PaymentsforRetirementOfCommonStock
1116000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1511000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1670000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
84814000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133666000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24543000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4704000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79920000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33659000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104463000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38363000
us-gaap Interest Paid Net
InterestPaidNet
960000
us-gaap Interest Paid Net
InterestPaidNet
2048000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1164000
us-gaap Income Taxes Paid
IncomeTaxesPaid
168000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2730000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3108000
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
73000
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
325000
us-gaap Stock Issued1
StockIssued1
339000
us-gaap Stock Issued1
StockIssued1
111000
us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
549000
CY2021Q2 efsi Consolidated Financial Ownership Wholly Owned Subsidiary Percentage
ConsolidatedFinancialOwnershipWhollyOwnedSubsidiaryPercentage
1
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
500000
efsi Deferred Compensation Arrangements Unrecognized Compensation Cost Related To Unvested Restricted Stock
DeferredCompensationArrangementsUnrecognizedCompensationCostRelatedToUnvestedRestrictedStock
673000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
26630
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
11925
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
31.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
10258
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
31.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
9933
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
31.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
425
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
31.05
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
36875
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.04
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3409689
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
20480
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.90
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3433387
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3430131
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3423387
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
143000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1131000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
880000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
24000
CY2021Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
175093000
CY2021Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2656000
CY2021Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1258000
CY2021Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
176491000
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
160827000
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4174000
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
46000
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
164955000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
15900000
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
143000
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
119
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
24900000
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
529000
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2021Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
90882000
CY2021Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1258000
CY2021Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
90882000
CY2021Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1258000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
12014000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
46000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
12014000
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
46000
CY2021Q2 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
27
CY2020Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
3
CY2021Q2 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
3100000
CY2021Q2 us-gaap Restricted Investments
RestrictedInvestments
1045000
CY2020Q4 us-gaap Restricted Investments
RestrictedInvestments
1267000
CY2021Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
876567000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
835649000
CY2021Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
802000
CY2020Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
685000
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
8098000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7096000
CY2021Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
869271000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
829238000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7096000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
883000
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1457000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
655000
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
814328000
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7096000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
24000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
143000
CY2021Q2 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
883000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8098000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
58000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
465000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
143000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8098000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7096000
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6365000
CY2021Q2 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
1750000
CY2021Q2 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
874817000
CY2021Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
876567000
CY2021Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
500000
CY2021Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4432000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
1862000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
833787000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
835649000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4754000
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
8040000
CY2021Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
876567000
CY2021Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
6748000
CY2021Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
869819000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4973000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
465000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1131000
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1457000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7096000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
72000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7024000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
835649000
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7768000
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
827881000
CY2021Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
7452000
CY2021Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
6762000
CY2021Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
58000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
6845000
us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
61000
CY2021Q2 efsi Accrued Interests And Net Deferred Loan Fees
AccruedInterestsAndNetDeferredLoanFees
14000
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8835000
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7785000
CY2020 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
8025000
CY2020 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
186000
CY2020Q4 efsi Accrued Interests And Net Deferred Loan Fees
AccruedInterestsAndNetDeferredLoanFees
17000
CY2021Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
834280000
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
17
CY2021Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
2800000
CY2020Q4 us-gaap Time Deposits
TimeDeposits
128658000
CY2021Q2 us-gaap Deposits Domestic
DepositsDomestic
1099398000
CY2020Q4 us-gaap Deposits Domestic
DepositsDomestic
1013098000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P17Y
CY2020 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
17
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3300000
CY2021Q2 efsi Financing Receivable Modifications Nonaccrual Numberof Contracts
FinancingReceivableModificationsNonaccrualNumberofContracts
3
CY2021Q2 efsi Financing Receivable Modifications Nonaccrual Recorded Investment
FinancingReceivableModificationsNonaccrualRecordedInvestment
809000
CY2020Q4 efsi Financing Receivable Modifications Nonaccrual Numberof Contracts
FinancingReceivableModificationsNonaccrualNumberofContracts
3
CY2020Q4 efsi Financing Receivable Modifications Nonaccrual Recorded Investment
FinancingReceivableModificationsNonaccrualRecordedInvestment
796000
CY2020Q4 efsi Number Of Deferral Loans Of Interest And Principal Payments
NumberOfDeferralLoansOfInterestAndPrincipalPayments
255
CY2021Q2 efsi Number Of Deferral Loans Of Interest And Principal Payments
NumberOfDeferralLoansOfInterestAndPrincipalPayments
2
CY2021Q2 efsi Number Of Loans Making Payment After Deferral Option Passed
NumberOfLoansMakingPaymentAfterDeferralOptionPassed
254
CY2021Q2 efsi Finance Receivable Modifications Amounts
FinanceReceivableModificationsAmounts
107000000.0
CY2021Q2 efsi Troubled Debt Restructuring Modifications Number Of Contracts
TroubledDebtRestructuringModificationsNumberOfContracts
1
CY2021Q2 efsi Troubled Debt Restructuring Modifications Pre Modification Recorded Investment
TroubledDebtRestructuringModificationsPreModificationRecordedInvestment
4000
CY2021Q2 efsi Troubled Debt Restructuring Modifications Post Modification Recorded Investment
TroubledDebtRestructuringModificationsPostModificationRecordedInvestment
4000
efsi Troubled Debt Restructuring Modifications Number Of Contracts
TroubledDebtRestructuringModificationsNumberOfContracts
3
efsi Troubled Debt Restructuring Modifications Post Modification Recorded Investment
TroubledDebtRestructuringModificationsPostModificationRecordedInvestment
113000
CY2021Q2 efsi Troubled Debt Restructuring Modifications By Granting Concession Number Of Contract
TroubledDebtRestructuringModificationsByGrantingConcessionNumberOfContract
1
efsi Troubled Debt Restructuring Modifications By Granting Concession Number Of Contract
TroubledDebtRestructuringModificationsByGrantingConcessionNumberOfContract
3
CY2021Q2 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2020Q2 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2021Q2 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
441051000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
407576000
CY2021Q2 us-gaap Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now
InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW
151275000
CY2020Q4 us-gaap Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now
InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW
132249000
CY2021Q2 us-gaap Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
221727000
CY2020Q4 us-gaap Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
207837000
CY2021Q2 us-gaap Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
159267000
CY2020Q4 us-gaap Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
136778000
CY2021Q2 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
532269000
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
476864000
CY2021Q2 efsi Time Deposits Lessthan250000
TimeDepositsLessthan250000
58420000
CY2020Q4 efsi Time Deposits Lessthan250000
TimeDepositsLessthan250000
59621000
CY2021Q2 efsi Time Deposits250000or More
TimeDeposits250000orMore
67658000
CY2020Q4 efsi Time Deposits250000or More
TimeDeposits250000orMore
69037000
CY2021Q2 us-gaap Time Deposits
TimeDeposits
126078000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P17Y
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0335
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0334
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
86000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
82000
us-gaap Operating Lease Cost
OperatingLeaseCost
151000
us-gaap Operating Lease Cost
OperatingLeaseCost
156000
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
321000
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
8000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
8000
CY2021Q2 us-gaap Lease Cost
LeaseCost
90000
CY2020Q2 us-gaap Lease Cost
LeaseCost
86000
us-gaap Lease Cost
LeaseCost
159000
us-gaap Lease Cost
LeaseCost
164000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
71000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
80000
us-gaap Operating Lease Payments
OperatingLeasePayments
126000
us-gaap Operating Lease Payments
OperatingLeasePayments
138000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
318000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
324000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
332000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
352000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3927000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5574000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1521000
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
176491000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
164955000
CY2021Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
104463000
CY2021Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
176491000
CY2021Q2 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
1045000
CY2021Q2 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
1073000
CY2021Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
869271000
CY2021Q2 efsi Accrued Interest Receivable Fair Value Disclosure
AccruedInterestReceivableFairValueDisclosure
2724000
CY2021Q2 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
22931000
CY2021Q2 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
1099398000
CY2021Q2 us-gaap Accrued Liabilities Fair Value Disclosure
AccruedLiabilitiesFairValueDisclosure
33000
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
79920000
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
164955000
CY2020Q4 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
1267000
CY2020Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
829238000
CY2020Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
12709000
CY2020Q4 efsi Accrued Interest Receivable Fair Value Disclosure
AccruedInterestReceivableFairValueDisclosure
3441000
CY2020Q4 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
1013098000
CY2020Q4 us-gaap Accrued Liabilities Fair Value Disclosure
AccruedLiabilitiesFairValueDisclosure
72000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1086000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4298000
CY2021Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-7000
CY2020Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
72000
CY2021Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-52000
CY2020Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
529000
CY2021Q2 efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
9000
CY2020Q2 efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
-96000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
36000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-361000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1122000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3937000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3279000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1482000
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-2706000
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
3637000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
24000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
529000
efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
-573000
efsi Other Comprehensive Income Loss Tax Effect Of Current Period Changes
OtherComprehensiveIncomeLossTaxEffectOfCurrentPeriodChanges
653000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2157000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2455000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1122000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3937000
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
607000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
183000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
183000
us-gaap Other Real Estate Additions
OtherRealEstateAdditions
73000
CY2020 us-gaap Other Real Estate Additions
OtherRealEstateAdditions
441000
us-gaap Other Real Estate Additions
OtherRealEstateAdditions
310000
CY2020 efsi Other Real Estate Gain On Foreclosure
OtherRealEstateGainOnForeclosure
166000
efsi Other Real Estate Gain On Foreclosure
OtherRealEstateGainOnForeclosure
132000
us-gaap Other Real Estate Disposals
OtherRealEstateDisposals
165000
CY2020 us-gaap Other Real Estate Disposals
OtherRealEstateDisposals
183000
us-gaap Other Real Estate Disposals
OtherRealEstateDisposals
183000
us-gaap Other Real Estate Valuation Adjustments
OtherRealEstateValuationAdjustments
92000
CY2021Q2 us-gaap Other Real Estate
OtherRealEstate
423000
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
607000
CY2020Q2 us-gaap Other Real Estate
OtherRealEstate
442000
us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
115000
efsi Affordable Housing Tax Creditsand Other Tax Benefits Expectedto Be Received
AffordableHousingTaxCreditsandOtherTaxBenefitsExpectedtoBeReceived
363000
us-gaap Affordable Housing Tax Credits And Other Tax Benefits Amount
AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount
182000
us-gaap Affordable Housing Tax Credits And Other Tax Benefits Amount
AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount
173000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NOTE 13. Recent Accounting Pronouncements and Other Authoritative Guidance</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.”  The amendments in this ASU, among other things, require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. In addition, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. At the FASB’s October 16, 2019 meeting, the Board affirmed its decision to amend the effective date of this ASU for many companies.  Smaller reporting companies who file with the U.S. Securities and Exchange Commission (SEC) and all other entities who do not file with the SEC are required to apply the guidance for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company is currently assessing the impact that ASU 2016-13 will have on its consolidated financial statements.<span style="font-style:italic;"> </span>The Company formed a CECL committee during 2016 which continues to meet weekly to address the compliance requirements.  Historic loan data has been gathered and reviewed for completeness and accuracy.  In addition, the committee has selected a third-party that is assisting in calculating the financial impact of ASU 2016-13 and anticipates running parallel allowance models under the current and new standard in advance of the required implementation date.</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective November 25, 2019, the SEC adopted Staff Accounting Bulletin (“SAB”) 119.  SAB 119 updated portions of SEC interpretative guidance to align with FASB ASC 326, “Financial Instruments - Credit Losses.”  It covers topics including (1) measuring current expected credit losses; (2) development, governance, and documentation of a systematic methodology; (3) documenting the results of a systematic methodology; and (4) validating a systematic methodology.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br/></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the FASB issued ASU No. 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” These amendments provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. It is intended to help stakeholders during the global market-wide reference rate transition period. The guidance is effective for all entities as of March 12, 2020 through December 31, 2022. Subsequently, in January 2021, the FASB issued ASU No. 2021-01 “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The ASU also amends the expedients and exceptions in Topic 848 to capture the incremental consequences of the scope clarification and to tailor the existing guidance to derivative instruments affected by the discounting transition. An entity may elect to apply ASU No. 2021-01 on contract modifications that change the interest rate used for margining, discounting, or contract price alignment retrospectively as of any date from the beginning of the interim period that includes March 12, 2020, or prospectively to new modifications from any date within the interim period that includes or is subsequent to January 7, 2021, up to the date that financial statements are available to be issued. An entity may elect to apply ASU No. 2021-01 to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020, and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020.The Company is assessing ASU 2020-04 and its impact on the Company’s transition away from LIBOR for its loans.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Developments</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, the Consolidated Appropriates Act of 2021 (“CAA”) was passed.  Under Section 541 of the CAA, Congress extended or modified many of the relief programs first created by the CARES Act, including the PPP loan program and treatment of certain loan modifications related to the COVID-19 pandemic. Refer to Note 6. Troubled Debt Restructurings <span style="color:#212529;">for further discussion regarding details of loan modifications. </span></p>
CY2021Q2 efsi Other Real Estate Gross
OtherRealEstateGross
515000
CY2020Q4 efsi Other Real Estate Gross
OtherRealEstateGross
607000
CY2021Q2 us-gaap Real Estate Owned Valuation Allowance
RealEstateOwnedValuationAllowance
92000
CY2021Q2 us-gaap Other Real Estate
OtherRealEstate
423000
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
607000
CY2021Q2 efsi Mortgage Loans In Process Of Foreclosure Number
MortgageLoansInProcessOfForeclosureNumber
1
CY2021Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
193000
CY2020Q4 efsi Mortgage Loans In Process Of Foreclosure Number
MortgageLoansInProcessOfForeclosureNumber
1
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
68000
CY2021Q2 us-gaap Amortization Method Qualified Affordable Housing Project Investments
AmortizationMethodQualifiedAffordableHousingProjectInvestments
2700000
CY2020Q4 us-gaap Amortization Method Qualified Affordable Housing Project Investments
AmortizationMethodQualifiedAffordableHousingProjectInvestments
2800000
CY2021Q2 us-gaap Qualified Affordable Housing Project Investments Commitment
QualifiedAffordableHousingProjectInvestmentsCommitment
23000
CY2020Q4 us-gaap Qualified Affordable Housing Project Investments Commitment
QualifiedAffordableHousingProjectInvestmentsCommitment
446000
CY2021Q2 us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
57000
CY2020Q2 us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
57000
us-gaap Amortization Method Qualified Affordable Housing Project Investments Amortization
AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization
115000

Files In Submission

Name View Source Status
0001564590-21-044300-index-headers.html Edgar Link pending
0001564590-21-044300-index.html Edgar Link pending
0001564590-21-044300.txt Edgar Link pending
0001564590-21-044300-xbrl.zip Edgar Link pending
efsi-10q_20210630.htm Edgar Link pending
efsi-10q_20210630_htm.xml Edgar Link completed
efsi-20210630.xsd Edgar Link pending
efsi-20210630_cal.xml Edgar Link unprocessable
efsi-20210630_def.xml Edgar Link unprocessable
efsi-20210630_lab.xml Edgar Link unprocessable
efsi-20210630_pre.xml Edgar Link unprocessable
efsi-ex311_7.htm Edgar Link pending
efsi-ex312_8.htm Edgar Link pending
efsi-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending